In an NIH-sponsored, double-blind three-way–crossover randomized trial, 210 adults with uncontrolled asthma who were receiving low-dose ICs (beclomethasone, 80 µg twice daily) were treated ...
In addition, ICS-SABA and ICS-formoterol were associated with "modest" improvements in asthma control, without the risk of an increase in adverse events. "Anti-inflammatory relievers are superior to ...